Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 205-351-5 | CAS number: 139-07-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
![](https://echa.europa.eu./o/diss-blank-theme/images/factsheets/A-REACH/factsheet/print_toxicological-information.png)
Toxicity to reproduction
Administrative data
- Endpoint:
- two-generation reproductive toxicity
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1990
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 990
- Report date:
- 1990
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- EPA OPP 83-4 (Reproduction and Fertility Effects)
- Deviations:
- no
- GLP compliance:
- yes
- Limit test:
- no
Test material
- Reference substance name:
- Quaternary ammonium compounds, benzyl C12-C16 (even numbered)-alkyldimethyl chlorides
- EC Number:
- 939-253-5
- Molecular formula:
- C12-16H25-33-(CH3)2-C6H5-N.CL
- IUPAC Name:
- Quaternary ammonium compounds, benzyl C12-C16 (even numbered)-alkyldimethyl chlorides
- Reference substance name:
- Free amine + amine hydrochloride
- IUPAC Name:
- Free amine + amine hydrochloride
- Test material form:
- liquid
Constituent 1
Constituent 2
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- Test animals
- Source: Sprague-Dawley CD rats were obtained from Charles River Breeding Laboratories, Kingston, NY, USA
- Age at study initiation: Six weeks
- Weight at study initiation: 212.2-213.4 g (males); 148.3-150.2 g (females)
- Housing: Individually in stainless steel, wire mesh cages (22.5x15.5x18.0 cm; mating cages 22.5x31.0x18.0 cm)
- Diet: Certified Ground Rodent Chow # 5002 (Ralstor Purina Co., St. Louis, MO), ad libitum
- Water: Tap water, ad libitum. Water was provided by an automatic watering system with demand control valves mounted on each cage rack.
- Acclimation period: Two weeks
Environmental conditions
- Temperature: 66-73°F
- Humidity: 40-60%
Administration / exposure
- Route of administration:
- oral: feed
- Vehicle:
- other: Certified Ground Rodent Chow # 5002
- Details on exposure:
- Diet preparation: A concentrated premix was prepared by direct addition of the test substance to ground chow and mixing for approximately an hour. Test diets were prepared by appropriate dilutions of the concentrated premix or higher diet concentrations.
- Rate of preparation of diet (frequency): Fresh diet was prepared weekly.
- Mixing appropriate amounts with (Type of food): Certified Ground Rodent Chow # 5002
- Storage temperature of food: Diets were stored in polyethylene containers at room temperature. - Details on mating procedure:
- - M/F ratio per cage: 1:1
- Mating procedure: After pre-breeding exposure the animals were mated on the basis of one male to one female selected randomly within each dose group for a period of 21d to produce F1 generation.
- Proof of pregnancy: Copulation plug and/or vaginal sperm as Day 0 of gestation.
- After the first 7d of the mating period females of unsuccessfully mated pairs were placed with males of other unmated pairs within the same dose group; after an additional 7d, unsuccessfully mated pairs were similarly exchanged again for a period of 7d or until successful mating had occurred, whichever came first, allowing for a total of 21d to mate.
- After successful mating each pregnant female was caged: Pregnant females were housed individually. On Day 20 of gestation each pregnant female was transferred to a shoe-box cage. - Analytical verification of doses or concentrations:
- yes
- Details on analytical verification of doses or concentrations:
- Experimental diets were analyzed for stability, homogeneity and concentration of test substance using high pressure liquid chromatography.
- Homogeneity study indicated that the distribution of the test substance in the test diet was uniform.
- Stability study indicated that the dosed feed was stable for at least 14d when stored in open glass feed jars at room temperature. Dosed feed was stable for at least 21d when stored in closed polyethylene containers at room temperature.
- Concentration verification analyses of the dosed feed indicated that the mean concentrations of the test substance in the diet for the 300, 1000 and 2000 ppm dosage levels were 95.3-109.0% of nominal for 300 ppm, 95.6-107.9% of nominal for 1000 ppm and 94.7-108.0% of nominal for 2000 ppm. - Duration of treatment / exposure:
- P0 generation: 19 weeks (from 1st prebreed dose to last F0 sacrifice)
F1 generation: 25 weeks (from 1st F1 wean to last F1 sacrifice)
F2 generation: Until weaning - Frequency of treatment:
- Daily
- Details on study schedule:
- - P1 parental animals not mated until 17-18 weeks after selection from the F1 litters.
- Selection of parents from F1 generation when pups were 28d old.
- Number of P1 generation animals selected: 28 males and 28 females
Doses / concentrations
- Remarks:
- Doses / Concentrations:
0, 300, 1000 or 2000 ppm test substance (i.e., equivalent to 0, 16-31, 51-102, and 100-188 mg/kg bw/day (males) and 0, 21-32, 67-106 and 139-198 mg/kg bw/day (females)).
Basis: nominal in diet
- No. of animals per sex per dose:
- 28
- Control animals:
- yes, plain diet
- Details on study design:
- - Rationale for animal assignment: Animals were randomly distributed based on body weight
- Animal identification: By ear tags
Examinations
- Parental animals: Observations and examinations:
- CAGE SIDE OBSERVATIONS: Yes
- Time schedule: Twice daily
CLINICAL SIGNS: Yes
- Time schedule: Once daily for overt clinical signs.
BODY WEIGHT: Yes
- Time schedule for examinations: Weekly during prebreed and mating for both sexes. For females on gestational Day 0, 6, 15, and 20 and on postnatal Day 0, 7, 14, and 21.
FOOD CONSUMPTION AND COMPOUND INTAKE: Yes
- Time schedule: Weekly during prebreed for both sexes. For females in 3- or 4-day intervals throughout gestation and to postnatal Day 14.
- Food consumption for each animal determined and mean daily diet consumption calculated as g food/kg body weight/day: Yes
WATER CONSUMPTION AND COMPOUND INTAKE: No - Litter observations:
- STANDARDISATION OF LITTERS
- Performed on day 4 postpartum: Yes, maximum of 8 pups/litter (4/sex/litter as nearly as possible). Excess pups were subjected to detailed external examination and then sacrificed.
PARAMETERS EXAMINED
The following parameters were examined in F1 and F2 offspring: Live/Still births on the day of birth (postnatal Day 0), survival indices at Days 0, 4, 7 and 14 after birth and weaning, weight on postnatal Day 1, 4, 7, 14, and at weaning (Day 21), and physical abnormalities for all pups at birth and throughout the pre-weaning period.
GROSS EXAMINATION OF DEAD PUPS: The thoracic and abdominal organs from pups which died after Day 4 were preserved for subsequent histopathological examination. - Postmortem examinations (parental animals):
- SACRIFICE: Yes
- How many animals: All animals
- Necropsy method: Animals were anesthetized with methoxyflurane and exsanguinated by severing the brachial vessel.
GROSS NECROPSY: Yes
- How many animals: All animals sacrificed in F0 and F1 parental animals
- Gross necropsy consisted of: Vagina, uterus, ovaries, gross lesions, testes, epididymis, seminal vesicles and prostrate.
HISTOPATHOLOGY : Yes
- How many animals: All animals of control and high dose groups sacrificed in P0 and P1 parental animals
- Tissues evaluated: Vagina, uterus, ovaries, gross lesions, testes, epididymis, seminal vesicles and prostrate and any tissues or organs showing gross alterations from the low and mid dose groups - Postmortem examinations (offspring):
- SACRIFICE
- The F1 offsprings not selected as parental animals and all F2 offsprings were sacrificed at 7d of age.
GROSS NECROPSY
- Examination for gross lesions was performed on any pup appearing abnormal or dying on test and for ten randomly selected F1 and F2 weanlings/sex/group. - Statistics:
- - The results of the quantitative continuous variables (e.g., body weights, food consumption, etc.) were compared between the three treatment groups and one control group using Levene’s test for equal variances, analysis of variance and (pooled or separate variance) t-test.
- Non-parametric data were statistically evaluated using the Kruskall-Wallis test followed by the Mann-Whitney U test for pairwise comparisons when appropriate.
- Frequency data were compared using the Fisher’s exact test. - Reproductive indices:
- Mating index, fertility index and gestational index were determined.
- Offspring viability indices:
- Live birth index, 4-d survival index, 7-d survival index, 14-d survival index, 21-d survival index and lactation index
Results and discussion
Results: P0 (first parental generation)
General toxicity (P0)
- Clinical signs:
- no effects observed
- Description (incidence and severity):
- No significant signs of toxicity during the pre-breed, mating, gestation or lactation periods at any dose for either generation were observed.
- Dermal irritation (if dermal study):
- not examined
- Mortality:
- no mortality observed
- Body weight and weight changes:
- effects observed, treatment-related
- Description (incidence and severity):
- - During the 10-week pre-breed exposure, F0 males exhibited no reduction in body weight. During the same period, F0 females at 2000 ppm exhibited reduction in body weight during Weeks 5, 6, 9 and 10 of pre-breed treatment. Body weight gain was also reduced at 2000 ppm for one week (Week 8-9) during the pre-breed period.
- On lactation Day 21 mean body weight of F0 dams at 2000 ppm exhibited a significant increase. Increased lactation body weight gain was observed at 2000 ppm throughout lactation. - Food consumption and compound intake (if feeding study):
- effects observed, treatment-related
- Description (incidence and severity):
- - Food consumption in the F0 females at 2000 ppm was reduced for the first four exposure weeks. Food consumption in F0 males was significantly reduced at 2000 ppm for the first week of treatment only.
- At F0 breed to produce F1 litters, food consumption during gestation and lactation was unaltered by treatment. - Food efficiency:
- not examined
- Water consumption and compound intake (if drinking water study):
- not examined
- Ophthalmological findings:
- not examined
- Haematological findings:
- not examined
- Clinical biochemistry findings:
- not examined
- Urinalysis findings:
- not examined
- Behaviour (functional findings):
- not examined
- Immunological findings:
- not examined
- Organ weight findings including organ / body weight ratios:
- no effects observed
- Histopathological findings: non-neoplastic:
- no effects observed
- Histopathological findings: neoplastic:
- not examined
- Other effects:
- effects observed, treatment-related
Reproductive function / performance (P0)
- Reproductive function: oestrous cycle:
- not examined
- Reproductive function: sperm measures:
- not examined
- Reproductive performance:
- no effects observed
- Description (incidence and severity):
- Mating index, fertility index and gestational index
No treatment-related effects on any reproductive parameters were observed at any dose; NOEL (parental) = 1000 ppm
Effect levels (P0)
open allclose all
- Key result
- Dose descriptor:
- NOAEL
- Remarks:
- systemic toxicity
- Effect level:
- 1 000 ppm
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- body weight and weight gain
- food consumption and compound intake
- Remarks on result:
- other: i.e., equivalent to 51-102 mg/kg bw/day (or 41-83 mg a.i./kg bw/day) in males and 67-106 mg/kg bw/day (or 54-86 mg a.i./kg bw/day) in females
- Key result
- Dose descriptor:
- NOEL
- Remarks:
- reproductive toxicity
- Effect level:
- 2 000 ppm
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- other: no reproductive toxicity observed
- Remarks on result:
- not determinable due to absence of adverse toxic effects
- Remarks:
- i.e., equivalent to 100-188 mg/kg bw/day (or 81-152 mg a.i./kg bw/day) in males and 139-198 mg/kg bw/day (or 113-161 mg a.i./kg bw/day) in females
Target system / organ toxicity (P0)
- Key result
- Critical effects observed:
- yes
- Lowest effective dose / conc.:
- 1 000 ppm
- System:
- other: body weight and food consumption
- Treatment related:
- yes
- Dose response relationship:
- yes
Results: P1 (second parental generation)
General toxicity (P1)
- Clinical signs:
- no effects observed
- Description (incidence and severity):
- No significant signs of toxicity during the pre-breed, mating, gestation or lactation periods at any dose for either generation were observed.
- Dermal irritation (if dermal study):
- not examined
- Mortality:
- no mortality observed
- Body weight and weight changes:
- effects observed, treatment-related
- Description (incidence and severity):
- At 2000 ppm, only slight reduction were observed in males and females
- Food consumption and compound intake (if feeding study):
- no effects observed
- Food efficiency:
- not examined
- Water consumption and compound intake (if drinking water study):
- not examined
- Ophthalmological findings:
- not examined
- Haematological findings:
- not examined
- Clinical biochemistry findings:
- not examined
- Urinalysis findings:
- not examined
- Behaviour (functional findings):
- not examined
- Immunological findings:
- not examined
- Organ weight findings including organ / body weight ratios:
- no effects observed
- Gross pathological findings:
- no effects observed
- Neuropathological findings:
- not examined
- Histopathological findings: non-neoplastic:
- no effects observed
- Histopathological findings: neoplastic:
- not examined
Reproductive function / performance (P1)
- Reproductive function: oestrous cycle:
- not examined
- Reproductive function: sperm measures:
- not examined
- Reproductive performance:
- no effects observed
- Description (incidence and severity):
- Mating index, fertility index and gestational index
Effect levels (P1)
open allclose all
- Key result
- Dose descriptor:
- NOAEL
- Remarks:
- systemic toxicity
- Effect level:
- 1 000 ppm
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- body weight and weight gain
- Remarks on result:
- other: i.e., equivalent to 51-102 mg/kg bw/day (or 41-83 mg a.i./kg bw/day) in males and 67-106 mg/kg bw/day (or 54-86 mg a.i./kg bw/day) in females
- Key result
- Dose descriptor:
- NOEL
- Remarks:
- reproductive toxicity
- Effect level:
- 2 000 ppm
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- other: no reproductive toxicity observed
- Remarks on result:
- not determinable due to absence of adverse toxic effects
- Remarks:
- i.e., equivalent to 100-188 mg/kg bw/day (or 81-152 mg a.i./kg bw/day) in males and 139-198 mg/kg bw/day (or 113-161 mg a.i./kg bw/day) in females
Target system / organ toxicity (P1)
- Key result
- Critical effects observed:
- yes
- Lowest effective dose / conc.:
- 2 000 ppm
- System:
- other: body weight
- Treatment related:
- yes
- Dose response relationship:
- yes
Results: F1 generation
General toxicity (F1)
- Clinical signs:
- no effects observed
- Description (incidence and severity):
- There were no signs of toxicity in the F1 or F2 animals.
- Dermal irritation (if dermal study):
- not examined
- Mortality / viability:
- no mortality observed
- Description (incidence and severity):
- There was no effects of treatment on postnatal deaths.
- Body weight and weight changes:
- effects observed, treatment-related
- Description (incidence and severity):
- The F1 litters exhibited reduced body weight per litter on postnatal Days 21 and 28 at 2000 ppm. F1 pup body weight gain was reduced during lactation Days 14-21 and 21-28.
- Food consumption and compound intake (if feeding study):
- not examined
- Food efficiency:
- not examined
- Water consumption and compound intake (if drinking water study):
- not examined
- Ophthalmological findings:
- not examined
- Haematological findings:
- not examined
- Clinical biochemistry findings:
- not examined
- Urinalysis findings:
- not examined
- Sexual maturation:
- not examined
- Organ weight findings including organ / body weight ratios:
- no effects observed
- Gross pathological findings:
- no effects observed
- Description (incidence and severity):
- There were no treatment-related observations or histopathological findings in either the F0 or F1 adult animals at any dose. There were no treatment-related findings in the F1 or F2 pups that died during lactation or randomly selected F1and F2 pups at necropsy.
- Histopathological findings:
- no effects observed
- Description (incidence and severity):
- There were no treatment-related observations or histopathological findings in either the F0 or F1 adult animals at any dose. There were no treatment-related findings in the F1 or F2 pups that died during lactation or randomly selected F1and F2 pups at necropsy.
Developmental neurotoxicity (F1)
- Behaviour (functional findings):
- not examined
Developmental immunotoxicity (F1)
- Developmental immunotoxicity:
- not examined
Details on results (F1)
Effect levels (F1)
open allclose all
- Key result
- Dose descriptor:
- NOAEL
- Remarks:
- general toxicity
- Generation:
- F1
- Effect level:
- 1 000 ppm
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- body weight and weight gain
- Remarks on result:
- other: i.e., equivalent to 51-102 mg/kg bw/day (or 41-83 mg a.i./kg bw/day) in males and 67-106 mg/kg bw/day (or 54-86 mg a.i./kg bw/day) in females
- Key result
- Dose descriptor:
- NOEL
- Remarks:
- developmental toxicity
- Generation:
- F1
- Effect level:
- 2 000 ppm
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- other: no effects observed
- Remarks on result:
- other: i.e., equivalent to 100-188 mg/kg bw/day (or 81-152 mg a.i./kg bw/day) in males and 139-198 mg/kg bw/day (or 113-161 mg a.i./kg bw/day) in females
Target system / organ toxicity (F1)
- Key result
- Critical effects observed:
- no
Results: F2 generation
General toxicity (F2)
- Clinical signs:
- no effects observed
- Description (incidence and severity):
- There were no signs of toxicity in the F1 or F2 animals.
- Dermal irritation (if dermal study):
- not examined
- Mortality / viability:
- no mortality observed
- Description (incidence and severity):
- There was no effects of treatment on postnatal deaths.
- Body weight and weight changes:
- effects observed, treatment-related
- Description (incidence and severity):
- F2 pup weights per litter were reduced at 2000 ppm on postnatal Day 28. Pup weight gain was also reduced at 2000 ppm during lactation Days 14-21 and for Days 21-28.
- Food consumption and compound intake (if feeding study):
- not examined
- Food efficiency:
- not examined
- Water consumption and compound intake (if drinking water study):
- not examined
- Ophthalmological findings:
- not examined
- Haematological findings:
- not examined
- Clinical biochemistry findings:
- not examined
- Urinalysis findings:
- not examined
- Sexual maturation:
- not examined
- Organ weight findings including organ / body weight ratios:
- no effects observed
- Gross pathological findings:
- no effects observed
- Description (incidence and severity):
- There were no treatment-related observations or histopathological findings in either the F0 or F1 adult animals at any dose. There were no treatment-related findings in the F1 or F2 pups that died during lactation or randomly selected F1and F2 pups at necropsy.
- Histopathological findings:
- no effects observed
Developmental neurotoxicity (F2)
- Behaviour (functional findings):
- not examined
Developmental immunotoxicity (F2)
- Developmental immunotoxicity:
- not examined
Details on results (F2)
Effect levels (F2)
open allclose all
- Key result
- Dose descriptor:
- NOAEL
- Remarks:
- general toxicity
- Generation:
- F2
- Effect level:
- 1 000 ppm
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- body weight and weight gain
- Remarks on result:
- other: i.e., equivalent to 51-102 mg/kg bw/day (or 41-83 mg a.i./kg bw/day) in males and 67-106 mg/kg bw/day (or 54-86 mg a.i./kg bw/day) in females
- Key result
- Dose descriptor:
- NOEL
- Remarks:
- developmental toxicity
- Generation:
- F2
- Effect level:
- 2 000 ppm
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- other: no effects observed
- Remarks on result:
- other: i.e., equivalent to 100-188 mg/kg bw/day (or 81-152 mg a.i./kg bw/day) in males and 139-198 mg/kg bw/day (or 113-161 mg a.i./kg bw/day) in females
Target system / organ toxicity (F2)
- Key result
- Critical effects observed:
- no
Overall reproductive toxicity
- Key result
- Reproductive effects observed:
- no
Applicant's summary and conclusion
- Conclusions:
- Under the study conditions, the rat NOAEL (systemic toxicity) for both parental generation (P0 and F1) and offspring (F1 and F2) was considered to be at 1000 ppm (in diet), i.e., equivalent to 51-102 mg/kg bw/day (or 41-83 mg a.i./kg bw/day) in males and 67-106 mg/kg bw/day (or 54-86 mg a.i./kg bw/day) in females, respectively. The rat NOEL (reproductive toxicity) although not specified by the authors in the study report, can be considered to be at the highest tested dose 2000 ppm (in diet), i.e., equivalent to 100-188 mg/kg bw/day (or 81-152 mg a.i./kg bw/day) in males and 139-198 mg/kg bw/day (or 113-161 mg a.i./kg bw/day) in females.
- Executive summary:
A two-generation study was conducted to determine the toxicity to reproduction of the test substance, C12-16 ADBAC (81.09% active in aqueous/ethanol solution) according to US EPA OPP 83-4, in compliance with GLP. The test substance was orally administered to Sprague-Dawley CD rats (28/sex/group) at dose levels of 0, 300, 1000 or 2000 ppm test substance (equivalent to average doses of 0, 16-31, 51-102, and 100-188 mg/kg bw/day for males and 0, 21-32, 67-106 and 139-198 mg/kg bw/day in females) in the diet. Following a 10-week pre-breed exposure period, the P0 rats were randomly paired within dose groups for a 3-week mating period to produce the F1 generation. Exposure continued through mating, gestation, parturition and lactation.
At weaning, twenty-eight (28) F1 weanling/sex/group were randomly selected and exposed to the same dietary concentration of the test substance as their parents for 10 weeks. After their pre-breed exposure, F1/P1 animals were paired to produce the F2 generation. The animals were observed twice daily and clinical findings, body weights and food consumption were recorded periodically. All P0 and F1 animals were necropsied and examined for gross lesions. Selected reproductive tissues from the high dose and control groups were examined histologically as were other tissues with gross lesions. Ten F1 and F2 weanlings/sex/dose were randomly selected and necropsied and examined for gross lesions. Remaining non-selected F1 and F2 pups at weaning were euthanised and discarded.
Reduced body weights in F0 males (but no F0 males or F1 males and females), reduced weight gain in F0 males and females and F1 males (but not F1 females) and reduced food consumption in F0 males and females and F1 males (but not F1 females) during the ten-week pre-breed exposures was observed. With the exception of body weights and food consumption in F0 females, reductions in the pre-breed parameters appeared transitory, disappearing after one or two weeks. Reproductive parameters were not affected in either of the two breeds (F1 or F2). At initiation of the gestational period, body weights of the F0 (but not F1) females at 2000 pp, were reduced; weight gains through-out gestation for both breeds were normal. Reduced gestations food consumption was observed in F1 females only.
F1 litters at 2000 ppm exhibited reduced body weights at weaning; both F1 and F2 generations of pups exhibited reduced body weights on Day 28 postpartum, one week subsequent to weaning. Body weight gains in both F1 and F2 litters were reduced for corresponding time intervals (lactational days 14-21 and 21-28) as well. The reduction in pup body weights (and weight gain) at 2000 ppm was considered to be treatment related as it corresponded to the time when the pups began to rely solely on the test substance diet as their source of nutrition. While the statistical reductions were observed only for female pup body weight gains on lactation days 21-28 in F1 litters and for male pups on days 14-21 in F2 litters, body weight gain reductions were apparent in both sexes of pups during these time periods. There were no treatment-related observations or histopathological findings in either the F0 or F1 adult animals at any dose. There were no treatment-related findings in the F1 or F2 pups that died during lactation or randomly selected F1and F2 pups at necropsy. Under the conditions of the study, it can be stated that, dietary administration of the test substance at dose levels of 0, 300, 1000 and 2000 ppm for two generations to Sprague-Dawley rats was well tolerated and no sign of reproductive toxicity was observed at any dose level. Also, there was no increased risk to the offspring in the absence of indications of maternal toxicity. The rat NOAEL (systemic toxicity) for both parental generation (P0 and F1) and offspring (F1 and F2) was considered to be at 1000 ppm (in diet), i.e., equivalent to 51-102 mg/kg bw/day (or 41-83 mg a.i./kg bw/day) in males and 67-106 mg/kg bw/day (or 54-86 mg a.i./kg bw/day) in females, respectively. The rat NOEL (reproductive toxicity) although not specified by the authors in the study report, can be considered to be at the highest tested dose 2000 ppm (in diet), i.e., equivalent to 100-188 mg/kg bw/day (or 81-152 mg a.i./kg bw/day) in males and 139-198 mg/kg bw/day (or 113-161 mg a.i./kg bw/day) in females (Neeper-Bradley, 1990).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
![ECHA](/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/echa_logo.png)